Articles by Desmond Hunt - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Desmond Hunt

USP Plans Standards on Good Distribution Practices

This article was originally published in the Nov. 2013 issue of BioPharm International.
Dec 18, 2013

USP is developing and revising distribution standards in response to changes in the global supply chain.

USP Seeks Input on Standards for Plastic Packaging Systems

USP seeks input from stakeholders on new and revised standards to mitigate extractables and leachables in plastic packaging systems.
Oct 2, 2013

USP seeks input from stakeholders on new and revised standards to mitigate extractables and leachables in plastic packaging systems.

Moisture Permeation of Pharmaceutical Packaging

USP is proposing a new performance testing standard for moisture permeation of pharmaceutical packaging.
Apr 2, 2013

USP is proposing a new performance testing standard for moisture permeation of pharmaceutical packaging.

Inside USP: US Pharmacopeia Proposes New Standard on Glass Quality

US Pharmacopeia documents best supply-chain practices and seeks broad input on proposal.
Jun 2, 2012

US Pharmacopeia documents best supply-chain practices and seeks broad input on proposal.

Inside USP: A Holistic Approach to Supply-Chain Integrity

US Pharmacopeia documents best supply-chain practices and seeks broad input on proposal.
Mar 2, 2012

US Pharmacopeia documents best supply-chain practices and seeks broad input on proposal.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
FindPharma Custom Search
Click here